coagulation factor XIII

coagulation factor XIII

 Factor XIII, see there.
References in periodicals archive ?
Objective: To provide a comprehensive literature review on roles of coagulation factor XIII (FXIII) in coagulation, wound healing, neoplasm, bone metabolism, and pregnancy.
Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII Asubunit in plasma and in cell lysates.
Food and Drug Administration today approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting disorder, known as congenital Factor XIII A-subunit deficiency.
Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastograpy.
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
Tetranucleotide repeat polymorphism at the human coagulation factor XIII A subunit gene (F13A1), Nucleic Acids Research (1991) 19:4036.
We developed a pyrosequencing-based genotyping protocol for parallel analysis of the [beta]-fibrinogen (-455G/A and -854 G/A), prothrombin (G20210A), coagulation factor V Leiden (G1691; Arg506G1n), coagulation factor VII (-401G/T and -402 G/A), coagulation factor XIII (G163T; Val34Leu), plasminogen activator inhibitor-1 (PAI-1; -675 4G/5G), methylenetetrahydrofolate reductase (MTHFR; C677T; Ala222Val), glycoprotein IIIa (GPIIIa; C1565T; Leu33Pro; also known as PlA1/ PlA2), and endothelial nitric oxide synthase (eNOS; G894T; G1u298Asp) polymorphisms, together with the cytochrome P450 2C9 [CYP2C9*1 (wild type)], CYP2C9*2 (C430T; Cys144Arg), CYP2C9*3 (A1075C; Ile359Leu), and CYP2C9*4 (T1076C; Ile359Thr) isoforms, which modulate the effect of warfarin in antithrombotic therapy.
This last fact draws attention to coagulation factor XIII (FXIII), which covalently cross-links fibrin by catalyzing the introduction of [gamma]-glutamyl-[epsilon]-lysine peptide bonds between fibrin [gamma]- and [alpha]-chains (19), and PAI-1, which plays a central role in controlling the fibrinolytic system.
Blood coagulation factor XIII (FXIII) [4] is a pro-transglutaminase of tetrameric structure ([A.